Aller au contenu principal
Profil bibliographique

Nahid Amini

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

39Publications signalées
993Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Medical Imaging Techniques and ApplicationsPhosphodiesterase function and regulationNeurotransmitter Receptor Influence on BehaviorReceptor Mechanisms and SignalingNeuroscience and Neuropharmacology Research

Les publications récentes

Accès ouvert 2025 article OpenAlex

Development of 18F/11C-Labeled Pyrrolo-Pyridine/Pyrimidine LRRK2 Selective PET Radioligands

Sangram Nag, Vladimir Aleksandrovich Stepanov, Akihiro Takano, Ryosuke Arakawa et autres

Background/Objectives: Leucine-rich repeat kinase 2 (LRRK2) is an enzyme implicated in Parkinson’s disease (PD) and a potential therapeutic target. LRRK2 PET radioligands could therefore function as imaging biomarkers for PD and as tools to measure enzyme occupancy of novel therapeutic candidates. This …

se, dk, hu (code pays fourni par la source)

2 citations Pharmaceuticals
Accès ouvert 2023 article OpenAlex

Microsome Mediated in Vitro Metabolism: A Convenient Method for the Preparation of the PET Radioligand Metabolite [18F]FE-PE2I-OH for Translational Dopamine Transporter Imaging

Magnus Schou, Nahid Amini, Akihiro Takano, Ryosuke Arakawa et autres

High Resolution Image Download MS PowerPoint Slide Undesired radiometabolites can be detrimental to the development of positron emission tomography (PET) radioligands. Methods for quantifying radioligand metabolites in brain tissue include ex vivo studies in small animals or labeling and imaging of the …

se (code pays fourni par la source)

0 citations ACS Chemical Neuroscience
Accès ouvert 2022 article OpenAlex

Target occupancy study and whole-body dosimetry with a MAGL PET ligand [11C]PF-06809247 in non-human primates

Ryosuke Arakawa, Akihiro Takano, Sangram Nag, Zhisheng Jia et autres

Abstract Background Monoacylglycerol lipase (MAGL) is a key serine hydrolase which terminates endocannabinoid signaling and regulates arachidonic acid driven inflammatory responses within the central nervous system. To develop [ 11 C]PF-06809247 into a clinically usable MAGL positron emission tomography (PET) radioligand, we …

se, us (code pays fourni par la source)

7 citations EJNMMI Research
Accès ouvert 2021 preprint OpenAlex

Target Occupancy Study and Whole-Body Dosimetry with a MAGL PET Ligand 11C-PF-06809247 in non-human Primates

Ryosuke Arakawa, Akihiro Takano, Sangram Nag, Zhisheng Jia et autres

Abstract BackgroundMonoacylglycerol lipase (MAGL) is a key serine hydrolase which terminates endocannabinoid signaling and regulates arachidonic acid driven inflammatory responses within the central nervous system (CNS). To develop [11C]PF-06809247 into a clinically usable positron emission tomography (PET) radioligand, we assessed the brain …

se, us (code pays fourni par la source)

0 citations Research Square
Accès ouvert 2018 article OpenAlex

Quantitative Analysis of 18F-PF-06684511, a Novel PET Radioligand for Selective β-Secretase 1 Imaging, in Nonhuman Primate Brain

Akihiro Takano, Laigao M. Chen, Sangram Nag, Michael A. Brodney et autres

β-secretase 1 (BACE1) is a key enzyme in the generation of β-amyloid, which is accumulated in the brain of Alzheimer disease patients. PF-06684511 was identified as a candidate PET ligand for imaging BACE1 in the brain and showed high specific binding in …

se, us (code pays fourni par la source)

7 citations Journal of Nuclear Medicine
Accès ouvert 2018 article OpenAlex

The metabotropic glutamate receptor 5 radioligand [11C]AZD9272 identifies unique binding sites in primate brain

Katarina Varnäs, Anders Juréus, Sjoerd J. Finnema, Peter Johnström et autres

The metabotropic glutamate receptor 5 (mGluR5) is a target for drug development and for imaging studies of the glutamate system in neurological and psychiatric disorders. [11C]AZD9272 is a selective mGluR5 PET radioligand that is structurally different from hitherto applied mGluR5 radioligands. In …

se (code pays fourni par la source)

13 citations Neuropharmacology
Accès ouvert 2018 article OpenAlex

A Nonhuman Primate PET Study: Measurement of Brain PDE4 Occupancy by Roflumilast Using (R)-[11C]Rolipram

Akihiro Takano, Tolga Uz, Jesus Garcia‐Segovia, Max C. Tsai et autres

Phosphodiesterase 4 (PDE4) inhibition in the brain has been reported to improve cognitive function in animal models. Therefore, PDE4 inhibitors are one of key targets potential for drug development. Investigation of brain PDE4 occupancy would help to understand the effects of PDE4 …

se, us, gb (code pays fourni par la source)

17 citations Molecular Imaging and Biology
2018 article OpenAlex

Development of [Carbonyl-11C]AZ13198083, a Novel Histamine Type-3 Receptor Radioligand with Favorable Kinetics

Kenneth Dahl, Ryuji Nakao, Nahid Amini, Mohammad Mahdi Moein et autres

The histamine subtype-3 receptor (H 3 R) is implicated in a range of central nervous system disorders, and several radioligands have been developed for H 3 R positron emission tomography imaging. However, a limitation of currently used PET radioligands for H 3 …

se (code pays fourni par la source)

11 citations ACS Chemical Neuroscience

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.